Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Acorda Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 149.4K | 159.5K | +10.2K (+6.8%) |
| Value | $1.94M | $2.30M | +$356.6K (+18.4%) |
New holders (3)
Institutions that held Acorda Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 10,734 | $160.9K | 0.00% |
| UBS Group AG | 134 | $2.01K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $15 | 0.00% |
Sold out (2)
Institutions that held Acorda Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Group One Trading, L.P. | 204 | $2.65K |
| FMR LLC | 1 | $13 |